PMID- 35210813 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220502 IS - 1178-7031 (Print) IS - 1178-7031 (Electronic) IS - 1178-7031 (Linking) VI - 15 DP - 2022 TI - Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis. PG - 1079-1097 LID - 10.2147/JIR.S347777 [doi] AB - PURPOSE: Chronic inflammation contributes to tumor initiation, progression, and immune escape. Neutrophils are the major component of inflammatory response and participate in the tumorigenesis process. However, compared to other immune cells in the tumor microenvironment of laryngeal squamous cell carcinoma (LSCC), neutrophils, especially the tumor-associated neutrophils (TANs), have not yet been comprehensively explored. The mechanism for regulating the crosstalk between TANs and tumor cells still remains unclear. MATERIALS AND METHODS: The distribution profiles and phenotypic features of neutrophils and other inflammatory immune cell populations from a large LSCC patient cohort were systemically analyzed. Co-culturing of peripheral blood associated neutrophils (PANs) and TANs with PBMCs was performed, and the immunosuppression effect on T-cells was examined. RESULTS: LSCC microenvironment is highly inflammatory with remarkable TANs infiltration, which is often associated with unfavorable prognosis and advanced clinical stage. We find that TANs in LSCC display morphologically immature and lower apoptosis, exhibit distinctively immunosuppressive phenotype of high PD-L1, and suppress CD8(+) T lymphocytes proliferation and activation. We subsequently discover that PD-L1(+)TANs induced by LSCC-derived GM-CSF potently impair CD8(+) T-cells proliferation and cytokines production function, which are partially blocked by a PD-L1-neutralizing antibody. Clinical data further support GM-CSF as an unfavorable prognostic biomarker and reveal a potential association with inflammatory immune cell infiltration, in particular neutrophils. CONCLUSION: Tumor-infiltrating PD-L1+ neutrophils induced by LSCC-derived GM-CSF suppress T cell proliferation and activation in the inflammatory microenvironment of LSCC and predict unfavorable prognosis. These TANs cripple antitumor T cell immunity and promote tumor progression. Our findings provide a basis for targeting PD-L1+TANs or GM-CSF as a new immunotherapeutic strategy for LSCC. CI - (c) 2022 Tang et al. FAU - Tang, Di AU - Tang D AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Zhang, Duo AU - Zhang D AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Heng, Yu AU - Heng Y AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Zhu, Xiao-Ke AU - Zhu XK AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Lin, Han-Qing AU - Lin HQ AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Zhou, Jian AU - Zhou J AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Tao, Lei AU - Tao L AD - Department of Otorhinolaryngology and ENT Institute, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. FAU - Lu, Li-Ming AU - Lu LM AD - Shanghai Institute of Immunology, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China. LA - eng PT - Journal Article DEP - 20220216 PL - New Zealand TA - J Inflamm Res JT - Journal of inflammation research JID - 101512684 PMC - PMC8859980 OTO - NOTNLM OT - GM-CSF OT - LSCC OT - PD-L1 OT - TANs OT - granulocyte-macrophage colony stimulating factor OT - immune suppression OT - inflammatory microenvironment OT - laryngeal squamous cell carcinoma OT - tumor-associated neutrophils COIS- The authors declare no conflict of interest in this work. EDAT- 2022/02/26 06:00 MHDA- 2022/02/26 06:01 PMCR- 2022/02/16 CRDT- 2022/02/25 05:36 PHST- 2021/11/11 00:00 [received] PHST- 2022/02/02 00:00 [accepted] PHST- 2022/02/25 05:36 [entrez] PHST- 2022/02/26 06:00 [pubmed] PHST- 2022/02/26 06:01 [medline] PHST- 2022/02/16 00:00 [pmc-release] AID - 347777 [pii] AID - 10.2147/JIR.S347777 [doi] PST - epublish SO - J Inflamm Res. 2022 Feb 16;15:1079-1097. doi: 10.2147/JIR.S347777. eCollection 2022.